trihexyphenidyl has been researched along with Bradycardia in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blumensohn, R | 1 |
| Razoni, G | 1 |
| Shalev, A | 1 |
| Munitz, H | 1 |
| Madill, HD | 1 |
| Stewart, WC | 1 |
| Savoie, ML | 1 |
2 other studies available for trihexyphenidyl and Bradycardia
| Article | Year |
|---|---|
Bradycardia due to trihexyphenidyl hydrochloride.
Topics: Adult; Bradycardia; Humans; Male; Trihexyphenidyl | 1986 |
Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning.
Topics: Animals; Antidotes; Atropine; Bradycardia; Carbachol; Central Nervous System; Cholinesterase Inhibit | 1968 |